Syuhada Zulkifli
Schein Ousts Three Top Executives Suddenly
Schein ousts top executives suddenly to simplify business and improve execution on its goals with new leadership team.
FDA Reconsiders Its Use of Artificial Intelligence
FDA reconsiders artificial intelligence use after commissioner departure, focusing on ai strategy and implementation, while ensuring regulatory compliance.
Boston Scientific Plans Restructuring $800M Charges Expected
Boston Scientific restructuring plan will incur up to $800 M in pre‑tax charges as the company shifts production and cuts jobs to…
User Account Blocked by Administrators
Prevent drug diversion with multidisciplinary auditing and procurement checks beyond diversion surveillance software effectively.
User Account Blocked by Moderators
Sacituzumab govitecan is a new first-line treatment option for breast cancer patients with metastatic triple-negative breast cancer.
User Blocked from Accessing System
Cancer patients often blur lines between cancer care and everyday medical management, requiring adaptability from oncologists and primary care doctors in cancer
Users Blocked From Accessing Website
Learn about the nonnegotiable bispecific dose protocols for safe administration in community oncology practices, as outlined by pharmacy leaders and experts.
Site Error Blocks Many Users Without Warning
A new study shows voice biomarkers on smartphones can detect worsening asthma or COPD flare-ups early, potentially reducing emergency hospital visits.
User Receives Unexpected Block Notification
Remote monitoring myasthenia study shows daily app tracking uncovers symptom swings missed in clinic visits, offering new insights for patient care.
User Blocked After Policy Violation
The veligrotug trial reveals a 2.9 mm reduction in proptosis for thyroid eye disease patients, offering a new FDA‑approved option beyond teprotumumab.